Innoviva, Inc. (INVA)
NASDAQ·Healthcare·Biotechnology
$21.00
+0.29%
Mkt Cap $1.49B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (10 analysts)
$38.00
Range $34.00 – $42.00
Implied Upside
+81.0%
Consensus $38.00 vs current $21.00
NASDAQ·Healthcare·Biotechnology
$21.00
+0.29%
Mkt Cap $1.49B
Buy
5
Hold
0
Sell
0
Price Target (10 analysts)
$38.00
Range $34.00 – $42.00
+81.0%
Consensus $38.00 vs current $21.00